Another pivotal study demonstrated that inhibiting EVs production in AD models significantly curtailed the propagation of tau, highlighting the therapeutic potential of targeting EVs pathways (Garcia-Contreras and Thakor, 2023). The gene discussed is MAPT; the disease is Alzheimer disease.